Program
Insulin Aspart
Also written as “insulin aspart”, “biphasic insulin aspart” and “Faster-acting insulin aspart”.
Its studies are mostly in Diabetes Mellitus, Type 2 · Diabetes Mellitus, Type 1 · Diabetes Mellitus · Diabetes, Gestational, led by 9 companies.
Drug pageInsulin Aspart: every studyMany companies study it; this page follows only the 139 they lead. All 207 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Novo Nordisk | 1280 open or running | phase 4since Nov 4, 2004 | Jul 17, 2003 | none ahead |
| Amphastar Pharmaceuticalsits history only | 20 open or running | phase 3since Sep 12, 2022 | Sep 12, 2022 | none ahead |
| Geropharmits history only | 20 open or running | phase 3since Sep 3, 2019 | Sep 3, 2019 | none ahead |
| Profil Institut für Stoffwechselforschungits history only | 20 open or running | phase 1since Aug 8, 2007 | Aug 8, 2007 | none ahead |
| CeQurits history only | 10 open or running | no phasesince Mar 24, 2015 | Mar 24, 2015 | none ahead |
| Defymedits history only | 11 open or running | no phasesince Dec 3, 2021 | Dec 3, 2021 | Dec 2026NCT05221359 |
| Sunshine Lake Pharmaits history only | 10 open or running | phase 3since Mar 6, 2023 | Mar 6, 2023 | none ahead |
| The United Laboratories Internationalits history only | 10 open or running | no phasesince May 6, 2026 | May 6, 2026 | none ahead |
| Tonghua Dongbao Pharmaceuticalits history only | 10 open or running | phase 3since Jun 5, 2015 | Jun 5, 2015 | none ahead |
Also a collaborator on its studies: Mylan and Sanofi.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Novo Nordisk only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 42 studies since Nov 8, 2011.
- Jan 7, 2014Phase 3 study in Diabetes MellitusNCT02034513 · 501 enrolled · United States, Poland, Puerto Rico
- Jan 9, 20143 phase 1 studies in Diabetes MellitusNCT02033239, NCT02035371, NCT02089451
- May 2, 2014Phase 1 study in Diabetes MellitusNCT02131246 · 33 enrolled · Austria
- Jul 15, 2015Phase 3 study in Diabetes MellitusNCT02500706 · 1,108 enrolled · United States, Austria, Bulgaria and more
- Oct 2, 20152 phase 1 studies in Diabetes MellitusNCT02568280, NCT02594033
- Jan 5, 20162 phase 3 studies in Diabetes MellitusNCT02648217, NCT02670915
- May 3, 2016Phase 3 study in Diabetes MellitusNCT02762578 · 543 enrolled · China
- Jul 4, 2016Phase 3 study in Diabetes MellitusNCT02825251 · 472 enrolled · United States, Belgium, Canada and more
- Jul 22, 2016Phase 1 study in HealthyNCT02844790 · 24 enrolled · China
- Sep 15, 2016Phase 3 study in Diabetes MellitusNCT02906917 · 532 enrolled · United States, Algeria, Czechia and more
- Oct 13, 2016Phase 1 study in Diabetes MellitusNCT02933853 · 61 enrolled · Austria
- Jun 29, 2017Phase 1 study in Diabetes MellitusNCT03215498 · 58 enrolled · Germany
- Jan 5, 2018Phase 1 study in Diabetes MellitusNCT03407599 · 46 enrolled · Germany
- Jan 23, 2019Phase 2 study in Diabetes Mellitus, Type 1NCT03816761 · 24 enrolled · United States
TargetBeta
“Insulin receptor agonist”ChEMBL 37, by rule
Other programs on INSR
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Insulin Glarginerule | Sanofi | phase 4 | 190 |
| insulin degludecrule | Novo Nordisk | phase 4 | 108 |
| Insulinrule | Pfizer | phase 4 | 50 |
| insulin glulisinerule | Sanofi | phase 4 | 43 |
| insulin icodecrule | Novo Nordisk | phase 4 | 30 |
| linsitinibrule | Astellas Pharma | phase 3 | 13 |
| LY3938577 | Eli Lilly | phase 2 | 3 |
Studies
The newest 60 of 128 Novo Nordisk leads. Each opens its study page. Every study on its drug page →
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT03816761Diabetes Mellitus, Type 1 · United States | 2 | Completed | May 31, 2019 | 24 |
| NCT03407599Diabetes Mellitus · Germany | 1 | Completed | Jul 5, 2018 | 46 |
| NCT03215498Diabetes Mellitus · Germany | 1 | Completed | Nov 20, 2017 | 58 |
| NCT02933853Diabetes Mellitus · Austria | 1 | Completed | Dec 21, 2017 | 61 |
| NCT02906917Diabetes Mellitus · United States, Algeria, Czechia and more | 3 | Completed | Aug 31, 2017 | 532 |
| NCT02844790Healthy · China | 1 | Completed | Sep 26, 2016 | 24 |
| NCT02825251Diabetes Mellitus · United States, Belgium, Canada and more | 3 | Completed | Jun 20, 2017 | 472 |
| NCT02762578Diabetes Mellitus · China | 3 | Completed | May 19, 2017 | 543 |
| NCT02670915Diabetes Mellitus · United States, Bulgaria, Czechia and more | 3 | Completed | Feb 5, 2018 | 834 |
| NCT02648217Diabetes Mellitus · Algeria, India, Lebanon and more | 3 | Completed | Sep 4, 2016 | 263 |
| NCT02594033Diabetes Mellitus · Germany | 1 | Completed | Jan 28, 2016 | 46 |
| NCT02568280Diabetes Mellitus · Austria | 1 | Completed | Apr 25, 2016 | 42 |
| NCT02500706Diabetes Mellitus · United States, Austria, Bulgaria and more | 3 | Completed | Jul 17, 2017 | 1,108 |
| NCT02131246Diabetes Mellitus · Austria | 1 | Completed | Jul 2014 | 33 |
| NCT02089451Diabetes Mellitus · Germany | 1 | Completed | Jun 6, 2014 | 21 |
| NCT02035371Diabetes Mellitus · Germany | 1 | Completed | Jul 24, 2014 | 41 |
| NCT02033239Diabetes Mellitus · Germany | 1 | Completed | Jun 2014 | 46 |
| NCT02034513Diabetes Mellitus · United States, Poland, Puerto Rico | 3 | Completed | Jan 11, 2016 | 501 |
| NCT02003677Diabetes Mellitus · Germany | 1 | Completed | Aug 14, 2014 | 67 |
| NCT01999322Diabetes Mellitus · United States, Germany | 3 | Completed | May 14, 2014 | 37 |
| NCT01992588Diabetes Mellitus · Germany | 1 | Completed | Mar 2014 | 48 |
| NCT01934712Diabetes Mellitus · Japan | 1 | Completed | Jan 28, 2014 | 50 |
| NCT01924637Diabetes Mellitus · Austria | 1 | Completed | Nov 2013 | 36 |
| NCT01892020Diabetes Mellitus · China | 4 | Completed | May 2014 | 161 |
| NCT01868568Diabetes Mellitus · Germany | 1 | Completed | Aug 2008 | 55 |
| NCT01868555Diabetes Mellitus · Japan | 1 | Completed | Feb 2008 | 32 |
| NCT01865331Diabetes Mellitus · Germany | 1 | Completed | Mar 2007 | 32 |
| NCT01865305Diabetes Mellitus · Germany | 1 | Completed | Feb 2007 | 59 |
| NCT01835431Diabetes Mellitus · United States, Belgium, Brazil and more | 3 | Completed | Nov 7, 2014 | 362 |
| NCT01814137Diabetes Mellitus · United States, Algeria, Germany and more | 3 | Completed | Mar 2014 | 40 |
| NCT01773798Diabetes Mellitus · Austria | 1 | Completed | Aug 2013 | 33 |
| NCT01713530Diabetes Mellitus · United States, Algeria, Austria and more | 3 | Completed | Jan 9, 2014 | 274 |
| NCT01707134Diabetes Mellitus · Austria, Denmark, Finland and more | 3 | Completed | May 2000 | 753 |
| NCT01704378Diabetes Mellitus · Finland, Norway, Sweden and more | 4 | Completed | Mar 14, 2003 | 89 |
| NCT01698697Diabetes Mellitus · South Africa | 1 | Completed | Oct 18, 2002 | 24 |
| NCT01682902Diabetes Mellitus · United States | 1 | Completed | Mar 2013 | 43 |
| NCT01650129Diabetes Mellitus · Japan | 3 | Completed | Oct 18, 2001 | 83 |
| NCT01620437Diabetes Mellitus · Japan | 1 | Completed | Dec 30, 2003 | 30 |
| NCT01620333Diabetes Mellitus · Japan | 1 | Completed | Apr 2000 | 24 |
| NCT01618188Diabetes Mellitus · Germany | 1 | Completed | Sep 7, 2012 | 52 |
| NCT01538511Diabetes Mellitus · Japan | 1 | Completed | Mar 13, 2007 | 59 |
| NCT01536028Diabetes Mellitus · Germany | 1 | Completed | Jul 2006 | 32 |
| NCT01530048Diabetes Mellitus · Denmark | 1 | Completed | May 2006 | 34 |
| NCT01527656Diabetes Mellitus · Germany | 1 | Completed | Feb 2004 | 40 |
| NCT01527643Diabetes Mellitus · Germany | 1 | Completed | Dec 17, 2003 | 30 |
| NCT01527630Diabetes Mellitus · Japan | 1 | Completed | Jan 8, 2003 | 30 |
| NCT01527565Diabetes Mellitus · South Africa | 1 | Completed | Feb 26, 2003 | 30 |
| NCT01527552Diabetes Mellitus · South Africa | 1 | Completed | Dec 18, 2002 | 30 |
| NCT01526980Diabetes Mellitus · United Kingdom | 2 | Completed | Nov 2002 | 31 |
| NCT01526941Diabetes Mellitus · Germany | 1 | Completed | Jul 2001 | 27 |
| NCT01524809Diabetes Mellitus · Denmark | 1 | Completed | Jun 2001 | 26 |
| NCT01523041Diabetes Mellitus · United Kingdom | 1 | Completed | Nov 30, 1999 | 24 |
| NCT01520831Diabetes Mellitus · Germany | 1 | Completed | May 2000 | 35 |
| NCT01520818Diabetes Mellitus · Belgium, France, Ireland and more | 3 | Completed | Apr 2001 | 666 |
| NCT01520753Diabetes Mellitus · Denmark | 3 | Completed | Jun 1999 | 16 |
| NCT01486966Diabetes Mellitus · China | 4 | Terminated | Jun 2012 | 58 |
| NCT01486940Diabetes Mellitus · Argentina, Croatia, Czech Republic and more | 3 | Completed | Oct 2002 | 598 |
| NCT01486914Diabetes Mellitus · United Kingdom | 1 | Completed | Feb 24, 2003 | 28 |
| NCT01649570Diabetes Mellitus · Japan | 4 | Completed | Aug 2003 | 123 |
| NCT01469143Diabetes Mellitus · Germany | 1 | Completed | Jan 2012 | 40 |
How it is read
Names in the registry
- “insulin aspart”, 60 entries
- “biphasic insulin aspart”, 27 entries
- “Faster-acting insulin aspart”, 24 entries
- “biphasic insulin aspart 50”, 13 entries
- “biphasic insulin aspart 70”, 12 entries
Conditions, from the studies’ own filings
- Diabetes Mellitus, Type 2, 57 studies
- Diabetes Mellitus, Type 1, 54 studies
- Diabetes Mellitus, 28 studies
- Diabetes, Gestational, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.